BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 30392786)

  • 21. BAMBI overexpression together with β-sitosterol ameliorates NSCLC via inhibiting autophagy and inactivating TGF-β/Smad2/3 pathway.
    Wang X; Li M; Hu M; Wei P; Zhu W
    Oncol Rep; 2017 May; 37(5):3046-3054. PubMed ID: 28440452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
    Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.
    Chai AW; Cheung AK; Dai W; Ko JM; Ip JC; Chan KW; Kwong DL; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lee VH; Lam AK; Pillai S; Law S; Lung ML
    Oncotarget; 2016 Nov; 7(48):78859-78871. PubMed ID: 27793011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducing apoptosis.
    He AR; Zhu Q; Gao S
    Biochem Biophys Res Commun; 2019 May; 513(2):494-501. PubMed ID: 30975469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
    Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
    Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2.
    Chien SY; Hsieh MJ; Chen CJ; Yang SF; Chen MK
    Expert Opin Ther Targets; 2015 Mar; 19(3):307-20. PubMed ID: 25563790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXA1 Expression in Nasopharyngeal Carcinoma: Association with Clinicopathological Characteristics and EMT Markers.
    Ammous-Boukhris N; Ayadi W; Derbel M; Allaya-Jaafar N; Charfi S; Daoud J; Sellami-Boudawara T; Mokdad-Gargouri R
    Biomed Res Int; 2020; 2020():4234632. PubMed ID: 32685483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
    Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
    Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-577/EIF5A2 axis suppressed the proliferation of DDP-resistant nasopharyngeal carcinoma cells by blocking TGF-β signaling pathway.
    Wu R; Zhong Q; Liu H; Liu S
    Chem Biol Drug Des; 2023 Oct; 102(4):815-827. PubMed ID: 37500510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival.
    Peng LX; Wang MD; Xie P; Yang JP; Sun R; Zheng LS; Mei Y; Meng DF; Peng XS; Lang YH; Qiang YY; Li CZ; Xu L; Liu ZJ; Guo LL; Xie DH; Shu DT; Lin ST; Luo FF; Huang BJ; Qian CN
    Cancer Lett; 2021 Feb; 498():165-177. PubMed ID: 33152401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.
    Liu ZF; Yang J; Wei SP; Luo XG; Jiang QS; Chen T; Gong YQ
    Kaohsiung J Med Sci; 2020 Nov; 36(11):895-903. PubMed ID: 32668092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
    He Q; Ren X; Chen J; Li Y; Tang X; Wen X; Yang X; Zhang J; Wang Y; Ma J; Liu N
    Oncotarget; 2016 Jan; 7(3):3047-58. PubMed ID: 26655091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A significant role of transcription factors E2F in inflammation and tumorigenesis of nasopharyngeal carcinoma.
    Liu P; Zhang X; Li Z; Wei L; Peng Q; Liu C; Wu Y; Yan Q; Ma J
    Biochem Biophys Res Commun; 2020 Apr; 524(4):816-824. PubMed ID: 32044038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.
    Wong AM; Kong KL; Chen L; Liu M; Wong AM; Zhu C; Tsang JW; Guan XY
    Int J Cancer; 2013 Nov; 133(10):2284-95. PubMed ID: 23649311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.